Losartan
Showing 26 - 50 of 468
Hypertension Trial (Losartan (+) amlodipine, Placebo to match losartan/amlodipine tablets, Amlodipine camsylate)
Completed
- Hypertension
- Losartan (+) amlodipine
- +3 more
- (no location specified)
Feb 7, 2022
Cardiorenal Effecs of Losartan in Kidney Transplant Recipients
Recruiting
- Renal Transplant Failure
- Cardiovascular Complication
- Losartan
-
Gdansk, PolandMedical University
Feb 3, 2022
Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection Trial in Minneapolis, Rochester (Losartan,
Completed
- Corona Virus Infection
- +2 more
- Losartan
- Placebo
-
Minneapolis, Minnesota
- +3 more
May 2, 2022
Type 2 Diabetes, High Blood Pressure Trial in Dallas (Polypill)
Not yet recruiting
- Type 2 Diabetes
- High Blood Pressure
-
Dallas, TexasUT Southwestern Medical Center
Nov 21, 2023
Oxidative Stress Trial in Guadalajara (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers)
Completed
- Oxidative Stress
- Angiotensin converting enzyme inhibitor
- Angiotensin Receptor Blockers
-
Guadalajara, Jalisco, MexicoEnrique Rojas Campos
Feb 8, 2022
Rheumatoid Arthritis, Cardiovascular Diseases Trial in Frederiksberg (Simvastatin, Losartan, Metformin)
Recruiting
- Rheumatoid Arthritis
- Cardiovascular Diseases
- Simvastatin
- +4 more
-
Frederiksberg, Region Of Copenhagen, DenmarkDepartment of Rheumathology, Frederiksberg and Bispebjerg univer
May 20, 2022
Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)
Not yet recruiting
- Coarctation of Aorta
- High Blood Pressure
- Losartan
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Heart Failure Trial (Losartan 50 mg, Losartan 150 mg)
Completed
- Heart Failure
- Losartan 50 mg
- Losartan 150 mg
- (no location specified)
Feb 3, 2022
Sickle Cell Disease, Diffuse Myocardial Fibrosis Trial in Cincinnati (Losartan)
Recruiting
- Sickle Cell Disease
- Diffuse Myocardial Fibrosis
- Losartan
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 7, 2021
Cystic Fibrosis Trial in Kansas City (Losartan)
Recruiting
- Cystic Fibrosis
- Losartan
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 15, 2022
Mild to Severe Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks,
Completed
- Mild to Severe Hypertension
- MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks
- losartan / Duration of Treatment: 6 weeks
- (no location specified)
Feb 7, 2022
Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:
Completed
- Type 2 Diabetes
- Nephropathy
- MK0954, losartan / Duration of Treatment: mean 3.4 years
- Placebo / Duration of Treatment: mean 3.4 years
- (no location specified)
Feb 7, 2022
Aortic Stenosis, Aortic Regurgitation, Hypertension Trial in Seoul (Amlodipine 5mg, Losartan, Losartan and Amlodipine)
Completed
- Aortic Stenosis
- +4 more
- Amlodipine 5mg
- +4 more
-
Seoul, Korea, Republic of10 Institutions Including Asan Medical Center
Sep 13, 2022
Femoroacetabular Impingement Trial in Vail (Fisetin, Placebo)
Recruiting
- Femoroacetabular Impingement
- Fisetin
- Placebo
-
Vail, ColoradoThe Steadman Clinic
May 3, 2022
Healthy Trial in Mexico City (Chlorthalidone (HIGROTON® 50), Losartan (COZZAR®), A1+ A2 Co-administration of Chlorthalidone and
Completed
- Healthy
- Chlorthalidone (HIGROTON® 50)
- +3 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Oct 20, 2021
Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)
Recruiting
- Proteinuria
- +3 more
- Azilsartan
- Losartan
-
Hanzhou, Zhejiang, Chinathe Second Afficiated Hospital, Zhejiang University, School of M
Feb 22, 2023
Hypertension Trial (Losartan 50 mg / HCTZ 12.5 mg)
Completed
- Hypertension
- Losartan 50 mg / HCTZ 12.5 mg
- (no location specified)
Feb 7, 2022
Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (Paricalcitol, Hydroxychloroquine, Losartan, Neoadjuvant therapy and
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Paricalcitol, Hydroxychloroquine, Losartan
- Neoadjuvant therapy and surgery only (Control)
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 7, 2022
Essential Arterial Hypertension Trial in Mexico City (Losartan/Chlorthalidone in fixed dose, Losartan + hydrochlorothiazide in
Not yet recruiting
- Essential Arterial Hypertension
- Losartan/Chlorthalidone in fixed dose
- Losartan + hydrochlorothiazide in fixed dose
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Jul 5, 2021
NAFLD - Nonalcoholic Fatty Liver Disease Trial in United States (Losartan potassium, Placebo losartan capsule)
Terminated
- NAFLD - Nonalcoholic Fatty Liver Disease
- Losartan potassium
- Placebo losartan capsule
-
San Diego, California
- +9 more
Sep 23, 2021
Breast Cancer Trial in Wuhan (Camrelizumab, Liposomal Doxorubicin, Losartan)
Not yet recruiting
- Breast Cancer
- Camrelizumab
- +2 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College of HUST
Oct 27, 2021
Sex Differences Trial in Iowa City (Compound 21, Compound 21 + losartan)
Recruiting
- Sex Differences
- Compound 21
- Compound 21 + losartan
-
Iowa City, IowaUniversity of Iowa
Oct 13, 2022